생식기 사마귀 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 5.4%의 연평균 복합 성장률(CAGR)로 25억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간 중의 성장은 원격 진료 및 치료 모니터링을 위한 원격의료 및 디지털 건강 플랫폼의 채택, STI에 대한 효과적이고 저렴한 치료에 대한 수요 증가, 루프 전기외과 절제술의 인기 증가, 인터페론 알파-n3 주사에 대한 수요 증가, 치료제물의 치료제의 가용성 증가 등에 기인하는 것으로 추정됩니다. 예측 기간 중 주요 동향으로는 진단 기술의 발전, 병용요법으로의 전환, 원격의료 및 온라인 진료의 확대, 새로운 치료 표적의 출현, 신흥 시장에서의 확대 등이 있습니다.
생식기 사마귀 시장의 성장을 촉진할 것으로 예상되는 성병(STI)은 주로 질, 항문, 구강 등 성접촉을 통해 감염되며, 세균, 바이러스, 기생충에 의해 감염되며, STI 유병률 증가는 성행위 증가, 보호 장비의 부적절한 사용, 교육 및 의료 서비스에 대한 접근성 제한으로 인해 발생합니다. 흔한 STI인 생식기 사마귀는 인유두종바이러스(HPV)의 특정 균주에 의해 발생하며, 성행위 중 피부와 피부의 직접적인 접촉을 통해 전파됩니다. 예를 들어 스위스에 본부를 둔 유엔 합동 에이즈 프로그램(Joint United Nations Programme on HIV/AIDS)은 2023년 10월 HIV 감염자가 2021년 3,870만 명에서 2022년 3,900만 명으로 증가하고 2022년에는 130만 명이 새로 감염될 것으로 예상했습니다. 보고했습니다. 이러한 STI의 확산은 생식기 사마귀 시장 확대에 박차를 가하고 있습니다.
생식기 사마귀 시장의 기업은 생식기 사마귀 환자의 요구를 충족시키기 위해 새로운 피부과 치료제와 같은 혁신적인 치료 옵션 개발에 주력하고 있습니다. 피부과 치료제는 생식기 사마귀를 포함한 다양한 피부 질환을 치료하기 위해 새롭게 개발된 의약품입니다. 예를 들어 2023년 3월 미국 피부과 기업 Verrica Pharmaceuticals Inc.는 자사의 의약품 후보물질인 YCANTH에 대해 FDA로부터 NCE(New Chemical Entity) 지위를 획득했습니다. 임상 2상을 마친 YCANTH는 생식기 사마귀 치료제로 개발되고 있으며, NCE 지위를 획득함에 따라 최소 5년간 제네릭 의약품과의 경쟁에서 보호받게 되었습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 성기 사마귀PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 성기 사마귀 시장 : 성장률 분석
- 세계의 성기 사마귀 시장 실적 : 규모와 성장, 2019-2024
- 세계의 성기 사마귀 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 성기 사마귀 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 성기 사마귀 시장 : 약제 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Imiquimod
- Podophyllin
- Podofilox
- Trichloroacetic Acid
- 세계의 성기 사마귀 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 화학 치료
- 절제 치료
- 예방 치료
- 기타 치료법
- 세계의 성기 사마귀 시장 : 성별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 여성
- 남성
- 세계의 성기 사마귀 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 클리닉
- 홈케어 설정
- 세계의 성기 사마귀 시장 Imiquimod의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Imiquimod 크림 5%
- Imiquimod 크림 3.75%
- 세계의 성기 사마귀 시장 Podophyllin의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Podophyllin 수지 10%
- Podophyllin 수지 25%
- 세계의 성기 사마귀 시장 Podofilox의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Podofilox 겔 0.5%
- Podofilox 용액 0.5%
- 세계의 성기 사마귀 시장 Trichloroacetic Acid의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Trichloroacetic Acid 80-90%
- Trichloroacetic Acid 50-70%
제7장 지역별·국가별 분석
- 세계의 성기 사마귀 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 성기 사마귀 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 성기 사마귀 시장 : 경쟁 구도
- 성기 사마귀 시장 : 기업 개요
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 3M Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Teva Pharmaceutical Industries Ltd.
- Bausch Health Companies Inc.
- Sun Pharmaceuticals
- Perrigo Company plc
- Glenmark Pharmaceutical Inc.
- Taro Pharmaceutical Industries Ltd.
- Serum Institute of India Pvt. Ltd.
- ANI Pharmaceuticals Inc.
- Ligand Pharmaceuticals Incorporated
- Orgenesis Inc.
- Verrica Pharmaceuticals Inc.
- CryoConcepts LP
- CryoIQ Global AB
- Cassiopea Inc.
- Aresus Pharma Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 성기 사마귀 시장 2029 : 새로운 기회를 제공하는 국가
- 성기 사마귀 시장 2029 : 새로운 기회를 제공하는 부문
- 성기 사마귀 시장 2029 : 성장 전략
제36장 부록
KSA
Genital warts, also known as condylomata acuminata, are sexually transmitted infections caused by specific strains of the human papillomavirus (HPV). These warts typically manifest as small growths or clusters of bumps in or around the genital and anal areas. They can vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Although generally painless, genital warts can lead to itching, discomfort, or bleeding during sexual intercourse.
The primary medications for treating genital warts include imiquimod, podophyllin, podofilox, and trichloroacetic acid. Imiquimod is a topical cream that works by stimulating the immune system to combat HPV-related warts. Treatment options also encompass chemical treatments, ablative treatments, preventive treatments, and other therapeutic approaches. These treatments are used by both females and males in various settings, such as hospitals, clinics, and home care environments.
The genital warts market research report is one of a series of new reports from The Business Research Company that provides genital warts market statistics, including genital warts industry global market size, regional shares, competitors with a genital warts market share, detailed genital warts market segments, market trends and opportunities, and any further data you may need to thrive in the genital warts industry. This genital warts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The genital warts market size has grown strongly in recent years. It will grow from $1.97 billion in 2024 to $2.08 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to the focus on patient-centered care, growing emphasis on early detection and treatment, increasing availability of therapies developed for self-target applications, and the increase in clinical trials and recurrence of genital warts.
The genital warts market size is expected to see strong growth in the next few years. It will grow to $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the adoption of telemedicine and digital health platforms for remote consultation and treatment monitoring, growing demand for effective and affordable treatments for STIs, the emerging popularity of loop electrosurgical excision procedures, the escalating demand for interferon alfa-n3 injection and increasing availability of therapies. Major trends in the forecast period include advancements in diagnostic technologies, a shift towards combination therapies, expansion of telehealth and online consultations, emergence of novel therapeutic targets, and expansion in emerging markets.
The rising prevalence of sexually transmitted infections (STIs) is expected to drive growth in the genital warts market. STIs, transmitted primarily through sexual contact such as vaginal, anal, and oral sex, are caused by bacteria, viruses, or parasites. The increase in STI prevalence is attributed to higher sexual activity, insufficient use of protection, and limited access to education and healthcare. Genital warts, a common STI, are caused by specific strains of human papillomavirus (HPV) and spread through direct skin-to-skin contact during sexual activity. For example, the Joint United Nations Programme on HIV/AIDS, based in Switzerland, reported in October 2023 that HIV infections rose from 38.7 million in 2021 to 39.0 million in 2022, with 1.3 million new infections in 2022. This growing prevalence of STIs is fueling the expansion of the genital warts market.
Companies in the genital warts market are focusing on developing innovative treatment options, such as new dermatology drugs, to address the needs of patients with genital warts. Dermatology drugs are newly developed pharmaceuticals aimed at treating various skin conditions, including genital warts. For instance, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology company, received New Chemical Entity (NCE) status from the FDA for its drug candidate YCANTH. YCANTH, which has completed phase 2 trials, is being developed to treat genital warts and will benefit from at least five years of protection from generic competition due to its NCE status.
In April 2024, Endo, Inc., a US-based pharmaceutical company specializing in generics and specialty-branded products, acquired Endo International plc for an undisclosed amount. This acquisition aims to bolster Endo, Inc.'s portfolio in both generic and specialty pharmaceuticals, enhancing its ability to support patients and healthcare providers. Endo International plc is also a US-based company specializing in generics and specialty-branded pharmaceuticals.
Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.
North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the genital warts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genital warts market consists of revenues earned by entities by providing services such as medical consultations, diagnostic testing, treatment procedures, follow-up care, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The genital warts market also includes sales of topical treatments, cryotherapy devices, surgical instruments, immune response modifiers, and antiviral medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genital Warts Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genital warts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genital warts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genital warts market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid
- 2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments
- 3) By Gender: Female; Male
- 4) By End Users: Hospitals; Clinics; Home Care Settings
Subsegmments
- 1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%
- 2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%
- 3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%
- 4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70%
- Companies Mentioned: Merck & Co.Inc.; AbbVie Inc; Sanofi S.A; Novartis AG; 3M Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Genital Warts Market Characteristics
3. Genital Warts Market Trends And Strategies
4. Genital Warts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Genital Warts Growth Analysis And Strategic Analysis Framework
- 5.1. Global Genital Warts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Genital Warts Market Growth Rate Analysis
- 5.4. Global Genital Warts Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Genital Warts Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Genital Warts Total Addressable Market (TAM)
6. Genital Warts Market Segmentation
- 6.1. Global Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Imiquimod
- Podophyllin
- Podofilox
- Trichloroacetic Acid
- 6.2. Global Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemical Treatment
- Ablative Treatment
- Preventive Treatment
- Other Treatments
- 6.3. Global Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Female
- Male
- 6.4. Global Genital Warts Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Home Care Settings
- 6.5. Global Genital Warts Market, Sub-Segmentation Of Imiquimod, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Imiquimod Cream 5%
- Imiquimod Cream 3.75%
- 6.6. Global Genital Warts Market, Sub-Segmentation Of Podophyllin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Podophyllin Resin 10%
- Podophyllin Resin 25%
- 6.7. Global Genital Warts Market, Sub-Segmentation Of Podofilox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Podofilox Gel 0.5%
- Podofilox Solution 0.5%
- 6.8. Global Genital Warts Market, Sub-Segmentation Of Trichloroacetic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Trichloroacetic Acid 80-90%
- Trichloroacetic Acid 50-70%
7. Genital Warts Market Regional And Country Analysis
- 7.1. Global Genital Warts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Genital Warts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Genital Warts Market
- 8.1. Asia-Pacific Genital Warts Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Genital Warts Market
- 9.1. China Genital Warts Market Overview
- 9.2. China Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Genital Warts Market
- 10.1. India Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Genital Warts Market
- 11.1. Japan Genital Warts Market Overview
- 11.2. Japan Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Genital Warts Market
- 12.1. Australia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Genital Warts Market
- 13.1. Indonesia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Genital Warts Market
- 14.1. South Korea Genital Warts Market Overview
- 14.2. South Korea Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Genital Warts Market
- 15.1. Western Europe Genital Warts Market Overview
- 15.2. Western Europe Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Genital Warts Market
- 16.1. UK Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Genital Warts Market
- 17.1. Germany Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Genital Warts Market
- 18.1. France Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Genital Warts Market
- 19.1. Italy Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Genital Warts Market
- 20.1. Spain Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Genital Warts Market
- 21.1. Eastern Europe Genital Warts Market Overview
- 21.2. Eastern Europe Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Genital Warts Market
- 22.1. Russia Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Genital Warts Market
- 23.1. North America Genital Warts Market Overview
- 23.2. North America Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Genital Warts Market
- 24.1. USA Genital Warts Market Overview
- 24.2. USA Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Genital Warts Market
- 25.1. Canada Genital Warts Market Overview
- 25.2. Canada Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Genital Warts Market
- 26.1. South America Genital Warts Market Overview
- 26.2. South America Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Genital Warts Market
- 27.1. Brazil Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Genital Warts Market
- 28.1. Middle East Genital Warts Market Overview
- 28.2. Middle East Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Genital Warts Market
- 29.1. Africa Genital Warts Market Overview
- 29.2. Africa Genital Warts Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Genital Warts Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Genital Warts Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Genital Warts Market Competitive Landscape And Company Profiles
- 30.1. Genital Warts Market Competitive Landscape
- 30.2. Genital Warts Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis
31. Genital Warts Market Other Major And Innovative Companies
- 31.1. Teva Pharmaceutical Industries Ltd.
- 31.2. Bausch Health Companies Inc.
- 31.3. Sun Pharmaceuticals
- 31.4. Perrigo Company plc
- 31.5. Glenmark Pharmaceutical Inc.
- 31.6. Taro Pharmaceutical Industries Ltd.
- 31.7. Serum Institute of India Pvt. Ltd.
- 31.8. ANI Pharmaceuticals Inc.
- 31.9. Ligand Pharmaceuticals Incorporated
- 31.10. Orgenesis Inc.
- 31.11. Verrica Pharmaceuticals Inc.
- 31.12. CryoConcepts LP
- 31.13. CryoIQ Global AB
- 31.14. Cassiopea Inc.
- 31.15. Aresus Pharma Inc.
32. Global Genital Warts Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Genital Warts Market
34. Recent Developments In The Genital Warts Market
35. Genital Warts Market High Potential Countries, Segments and Strategies
- 35.1 Genital Warts Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Genital Warts Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Genital Warts Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
